Swedish Orphan Biovitrum and Pharming sign Rhucin® distribution agreement

Goals, mission and background Business Strategy CEO'S STATEMENT History 10 year overview Press releases News Financial Reports Calendar Image gallery Presentations Corporate Governance

Home / ...

4/15/2010

Stockholm, Sweden and Leiden, The Netherlands – April 15, 2010
Swedish Orphan Biovitrum (STO: BVT) and Pharming Group NV (NYSE Euronext: PHARM) today announced an exclusive 10 year distribution agreement, under which Swedish Orphan Biovitrum will distribute Rhucin® in 24 EU countries, Norway, Iceland and Switzerland.

Please read the whole press release here.